Your browser doesn't support javascript.
loading
A Belgian consensus strategy to identify familial hypercholesterolaemia in the coronary care unit and its subsequent cascade screening and treatment: BEL-FaHST (The BELgium Familial Hypercholesterolaemia STrategy).
Descamps, Olivier S; Van Caenegem, Olivier; Hermans, Michel P; Balligand, Jean-Luc; Beauloye, Christophe; Bondue, Antoine; Carlier, Stéphane; Castermans, Emilie; Chenot, Fabien; Claeys, Marc; De Block, Christophe; de Leener, Anne; De Meester, Antoine; Demeure, Fabian; De Raedt, Herbert; Desmet, Walter; Elegeert, Ivan; Guillaume, Michel; Hoffer, Etienne; Kacenelenbogen, Raymond; Lancellotti, Patrizio; Langlois, Michel; Leone, Attilio; Mertens, Ann; Paquot, Nicolas; Vanakker, Olivier; Vanoverschelde, Jean-Louis; Verhaegen, Ann; Vermeersch, Pieter; Wallemacq, Caroline; Rietzschel, Ernst.
Afiliação
  • Descamps OS; Department of Internal Medicine, Centres Hospitaliers Jolimont, Haine Saint-Paul and Department of Cardiology, UCL Cliniques Universitaires Saint-Luc, Bruxelles, Belgium. Electronic address: olivier.descamps@jolimont.be.
  • Van Caenegem O; Department of Cardiology, UCL Cliniques Universitaires Saint-Luc, Bruxelles, Belgium.
  • Hermans MP; Department of Endocrinology & Nutrition, UCL, Cliniques Universitaires Saint-Luc, Bruxelles, Belgium.
  • Balligand JL; Department of Internal Medecine, Cliniques Universitaires Saint-Luc and Institut de Recherche Expérimentale et Clinique, UCL, Bruxelles, Belgium.
  • Beauloye C; Department of Cardiology, UCL Cliniques Universitaires Saint-Luc, Bruxelles, Belgium.
  • Bondue A; Department of Cardiology and Centre for Human Genetics, CUB Hôpital Erasme, Université Libre de Bruxelles, Brussels, Belgium.
  • Carlier S; Department of Cardiology, Centre Hospitalier Universitaire, Ambroise Paré and Mons University (UMONS), Mons, Belgium.
  • Castermans E; Department of Human Genetics, Centre Hospitalier Universitaire Sart Tilman, Liège, Belgium.
  • Chenot F; Department of Cardiology, Grand Hôpital de Charleroi, Belgium.
  • Claeys M; Department of Cardiology, University Hospital Antwerp, President of the Belgian Society of Cardiology, Belgium.
  • De Block C; Department of Endocrinology-diabetology-metabolism, UA Antwerp University Hospital, UA Universitair Ziekenhuis Antwerpen, Belgium.
  • de Leener A; Centre de Génétique Humaine, UCL Cliniques Universitaires Saint-Luc, Bruxelles, Belgium.
  • De Meester A; Department of Cardiology, Centres Hospitaliers Jolimont, Haine Saint-Paul, Belgium.
  • Demeure F; Department of Cardiology, Cliniques Universitaires de Mont-Godinne, Belgium.
  • De Raedt H; Department of Cardiology, Onze-Lieve-Vrouw Ziekenhuis, Aalst, Belgium.
  • Desmet W; Department of Cardiovascular Medicine, Universitaire Ziekenhuizen Leuven, University Hospitals Leuven, Belgium.
  • Elegeert I; Department of Cardiology, Algemeen Ziekenhuis, Groeninge, Kortrijk, Belgium.
  • Guillaume M; Department of Cardiology, Centre Hospitalier Universitaire de Charleroi, Belgium.
  • Hoffer E; Department of Cardiology, Centre Hospitalier Régional de la Citadelle, Liège, Belgium.
  • Kacenelenbogen R; Department of Cardiology, CHU Saint-Pierre and President of the Working Group of Cardiovascular Readaptation and Prevention, Belgium.
  • Lancellotti P; GIGA Cardiovascular Sciences, Department of Cardiology, Centre Hospitalier Universitaire Sart Tilman, Liège, Belgium.
  • Langlois M; Department of laboratory Medicine, Algemeen Ziekenhuis Sint-Jan, Brugge, and National Representative of the Royal Belgian Society of Laboratory Medicine, Belgium.
  • Leone A; Department of Cardiology, Centre Hospitalier Universitaire de Tivoli La Louvière, Belgium.
  • Mertens A; Department of Endocrinology, University Hospitals Leuven, Belgium.
  • Paquot N; GIGA I3, Department of Diabetes, Nutrition and Metabolic Diseases, Centre Hospitalier Universitaire Sart Tilman, Liège, Belgium.
  • Vanakker O; Center for Medical Genetics, Ghent University Hospital, Ghent, Belgium.
  • Vanoverschelde JL; Department of Cardiology, UCL Cliniques Universitaires Saint-Luc, Bruxelles, Belgium.
  • Verhaegen A; Department of Endocrinology, Diabetology and Metabolism, Antwerp University Hospital, Antwerpen, Belgium.
  • Vermeersch P; Department of laboratory Medicine, Senior Clinical Investigator of the Research Foundation-Flanders (FWO), University Hospital Leuven, The Royal Belgian Society of Laboratory Medicine, Belgium.
  • Wallemacq C; Department of Diabetes, Nutrition and Metabolic Diseases, Centre Hospitalier Universitaire Sart Tilman, Liège, Belgium.
  • Rietzschel E; Department of Cardiology, University Hospital Ghent and Ghent University, Belgium.
Atherosclerosis ; 277: 369-376, 2018 10.
Article em En | MEDLINE | ID: mdl-30270073
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças Cardiovasculares / Técnicas de Apoio para a Decisão / Procedimentos Clínicos / Unidades de Cuidados Coronarianos / Hiperlipoproteinemia Tipo II / LDL-Colesterol Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças Cardiovasculares / Técnicas de Apoio para a Decisão / Procedimentos Clínicos / Unidades de Cuidados Coronarianos / Hiperlipoproteinemia Tipo II / LDL-Colesterol Idioma: En Ano de publicação: 2018 Tipo de documento: Article